huA33 antibody (radio-labeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for huA33 antibody (radio-labeled), covering 2025-07-04 to 2025-07-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of Radio-labeled huA33 Antibody in Colorectal Cancer [NA]